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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 206 (FGE.206): 
Consideration of genotoxicity data on representatives for 12 alpha,beta-
unsaturated ketones and precursors from chemical subgroup 1.2.3 of 
FGE.19 by EFSA1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
SUMMARY 
The European Food Safety Authority (EFSA) asked the Scientific Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission 
on the implications for human health of chemically defined flavouring substances used in or on 
foodstuffs in the Member States. In particular, the Panel was requested to consider the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA) evaluations of flavouring substances 
assessed since 2000, and to decide whether no further evaluation is necessary, as laid down in 
Commission Regulation (EC) No 1565/2000. These flavouring substances are listed in the Register, 
which was adopted by Commission Decision 1999/217/EC and its consecutive amendments. 
The present Flavouring Group Evaluation 206 (FGE.206), corresponding to subgroup 1.2.3 of 
FGE.19, concerns seven aliphatic ketones and five precursors for such ketones. The 12 substances 
under consideration in the present evaluation are alpha,beta-unsaturated ketone structures or can be 
metabolised to such, which are considered to be structural alerts for genotoxicity and the data on 
genotoxicity previously available did not rule out the concern for genotoxicity. 
The Panel has identified two substances in subgroup 1.2.3 which will represent the other 10 substances 
in this subgroup. For these two substances, genotoxicity data according to the test strategy worked out 
by the Panel have been requested. 
                                                     
 
1  On request from the Commission, Question No EFSA-Q-2010-01248, adopted on 25 November 2010. 
2  Panel members: Arturo Anadon, Mona-Lise Binderup, Wilfried Bursch, Laurence Castle, Riccardo Crebelli, Karl-Heinz 
Engel, Roland Franz, Nathalie Gontard, Thomas Haertle, Trine Husøy, Klaus-Dieter Jany, Catherine Leclercq, Jean 
Claude Lhuguenot, Wim Mennes, Maria Rosaria Milana, Karla Pfaff, Kettil Svensson, Fidel Toldra, Rosemary Waring, 
Detlef Wölfle. Correspondence: cef-unit@efsa.europa.eu  
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on Genotoxicity of Flavourings for the 
preparation of this Opinion: Vibe Beltoft, Mona-Lise Binderup, Wilfried Bursch, Angelo Carere, Riccardo Crebelli, Karl-
Heinz Engel, Rainer Gürtler, John Christian Larsen, Wim Mennes, Karin Nørby and EFSA’s staff member Kim Rygaard 
Nielsen for the preparatory work on this scientific Opinion. 
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The Industry has submitted data concerning genotoxicity studies for the two representative substances 
for this subgroup. 
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] and pseudo-ionone [FL-no: 07.198] has been tested for 
all three genetic endpoints, gene mutations, structural and numerical chromosomal aberrations. The 
test compounds did not induce gene mutations in bacteria and were not clastogenic and/or aneugenic 
in mammalian cells in vitro.  
The Panel concluded that the in vitro genotoxicity data on these two representative substances do not 
indicate genotoxic potential. Accordingly, all 12 substances in FGE.19 subgroup 1.2.3 are not 
considered to be of concern with respect to genotoxicity and will then be evaluated through the 
Procedure. 
 
© European Food Safety Authority, 2011 
KEY WORDS 
FGE.19; subgroup 1.2.3, acyclic alpha,beta-unsaturated ketones with additional conjugated double-
bond. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
procedure for the establishment of a list of flavouring substances, the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a) which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
After the completion of the evaluation programme the Union list of flavouring substances for use in or 
on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
Flavouring Group Evaluation 19 (FGE.19) contains 360 flavouring substances from the EU Register 
being alpha, beta-unsaturated aldehydes or ketones and precursors which could give rise to such 
carbonyl substances via hydrolysis and / or oxidation (EFSA, 2008b). 
The alpha, beta-unsaturated aldehyde and ketone structures are structural alerts for genotoxicity. The 
Panel noted that there were limited genotoxicity data on these flavouring substances but that positive 
genotoxicity studies were identified for some substances in the group. 
The alpha, beta-unsaturated carbonyls were subdivided into 28 subgroups on the basis of structural 
similarity (EFSA, 2008b). In an attempt to decide which of the substances could go through the 
Procedure, a (quantitative) structure-activity relationship (Q)SAR prediction of the genotoxicity of 
these substances was undertaken considering a number of models (DEREKfW, TOPKAT, DTU-NFI-
MultiCASE Models and ISS-Local Models, (Gry et al., 2007)). 
The Panel noted that for most of these models internal and external validation has been performed, but 
considered that the outcome of these validations was not always extensive enough to appreciate the 
validity of the predictions of these models for these alpha, beta- unsaturated carbonyls. Therefore, the 
Panel considered it inappropriate to totally rely on (Q)SAR predictions at this point in time and 
decided not to take substances through the procedure based on negative (Q)SAR predictions only. 
The Panel took note of the (Q)SAR predictions by using two ISS Local Models (Benigni & Netzeva, 
2007a; Benigni & Netzeva, 2007b) and four DTU-NFI MultiCASE Models (Gry et al., 2007; Nikolov 
et al., 2007) and the fact that there are available data on genotoxicity, in vitro and in vivo, as well as 
data on carcinogenicity for several substances. Based on these data the Panel decided that 15 
subgroups (1.1.1, 1.2.1, 1.2.2, 1.2.3, 2.1, 2.2, 2.3, 2.5, 3.2, 4.3, 4.5, 4.6, 5.1, 5.2 and 5.3) (EFSA, 
2008b) could not be evaluated through the Procedure due to concern with respect to genotoxicity. 
Corresponding to these subgroups, 15 Flavouring Group Evaluations (FGEs) were established, 
FGE.200, 204, 205, 206, 207, 208, 209, 211, 215, 219, 221, 222, 223, 224 and 225). 
For 11 subgroups the Panel decided, based on the available genotoxicity data and (Q)SAR predictions, 
that a further scrutiny of the data should take place before requesting additional data from the 
Flavouring Industry on genotoxicity. These subgroups were evaluated in FGE.201, 202, 203, 210, 
212, 213, 214, 216, 217, 218 and 220. For the substances in FGE.202, 214 and 218 it was concluded 
that a genotoxic potential could be ruled out and accordingly these substances will be evaluated using 
the Procedure. For all or some of the substances in the remaining FGEs, FGE.201. 203, 210, 212, 213, 
216, 217 and 220 the genotoxic potential could not be ruled out. 
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To easy the data retrieval of the large number of structurally related alpha,beta-unsaturated substances 
in the different subgroups for which additional data are requested, EFSA has worked out a list of 
representative substances for each subgroup (EFSA, 2008bc). Likewise an EFSA genotoxicity expert 
group has worked out a test strategy to be followed in the data retrieval for these substances (EFSA, 
2008bb).  
The Flavouring Industry has been requested to submit additional genotoxicity data according to the list 
of representative substances and test strategy for each subgroup.   
The Flavouring industry has now submitted additional data and the present FGE concerns the 
evaluation of these data requested on genotoxicity. 
TERMS OF REFERENCE 
The European Commission requests the European Food Safety Authority to carry out an evaluation of 
the data on pseudo-ionone [FL-no: 07.198] and 6-methylhepta-3,5-dien-2-one [FL-no: 07.099], in 
accordance with Commission Regulation (EC) No 1565/2000. Depending on the outcome of the 
evaluations of these substances, the Europen Commission asks EFSA to evaluate all the substances of 
the corresponding subgroup (FGE.19 subgroup 1.2.3) through the Procedure. 
ASSESSMENT 
1. Presentation of the Substances in the JECFA Flavouring Group 
1.1. Description 
The present Flavouring Group Evaluation 206 (FGE.206), corresponding to subgroup 1.2.3 of 
FGE.19, concerns seven alpha,beta-unsaturated aliphatic ketones with additional double-bonds and 
five precursors for such ketones. The 12 substances under consideration in the present evaluation are 
listed in Table 1.  
Seven of the 12 substances have previously been evaluated by the JECFA. A summary of their current 
evaluation status by the JECFA and the outcome of this consideration is presented in Table 2. 
The alpha,beta-unsaturated aldehyde and ketone structures are considered to be structural alerts for 
genotoxicity (EFSA, 2008b) and the data on genotoxicity previously available did not rule out the 
concern for genotoxicity. 
1.2. Representative Substances for Subgroup 1.2.3 
The Panel has identified two substances in subgroup 1.2.3 which will represent all other 10 substances 
in this subgroup (EFSA, 2008bc). For these two substances genotoxicity data according to the test 
strategy (EFSA, 2008bb) have been requested. The representative substances are listed in Table 1.1. 
TABLE 1.1 REPRESENTATIVE SUBSTANCES FOR SUBGROUP 1.2.3 OF FGE.19  
FL-no  
JECFA-no  
Subgroup  EU Register name  Structural formula  FEMA no  
CoE no  
CAS no  
07.099  
1134  
1.2.3  6-Methylhepta-3,5-dien-2-one  O 3363  
11143  
1604-28-0  
07.198  
- 
1.2.3  Pseudo-ionone  O
 
-  
11191  
141-10-6  
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2. Additionally Submitted Genotoxicity Data on Representative Substances of Subgroup 
1.2.3 
Introduction 
The Industry has submitted data concerning genotoxicity studies for the two representative substances 
for this subgroup 
• 6-Methylhepta-3,5-dien-2-one [FL-no: 07.099], 
• pseudo-Ionone [FL-no: 07.198].  
2.1. In vitro Data 
In vitro genotoxicity assays have been performed on 6-methylhepta-3,5-dien-2-one and pseudo-
ionone. 
2.1.1.  Bacterial Reverse Mutation Assay 
6-Methylhepta-3,5-dien-2-one was tested in Salmonella typhimurium strains TA98, TA100, TA1535, 
TA1537 and TA102 in the presence or absence of S9. In the first experiment the concentrations tested 
were 1.6, 8, 40, 200, 1000 and 5000 μg/plate, and the plate incorporation methodology was used. 
Severe toxicity was observed at 5000 μg/plate in all strains (complete killing of bacteria). No increase 
in revertant colonies was observed at any of the tested concentrations. In the second experiment the 
concentrations were 20.5, 51.2, 128, 320, 800, 2000 and 5000 μg/plate of 6-methylhepta-3,5-dien-2-
one, and treatments in the presence of S9 were carried out according to the pre-incubation method. In 
the absence of S9 the standard plate incorporation method was performed. Slight thinning of the 
bacterial lawn or complete killing of the bacteria was observed in all strains at 2000 and 5000 μg/plate 
in the absence of S9. In the presence of S9 cytotoxicity was observed at 800 μg/plate and above and 
severe toxicity (complete killing of bacteria) was observed at 5000 μg/plate in all strains (Williams, 
2009). The study design complied with current recommendations (OECD 471; GLP) and an 
acceptable top concentration was achieved. There was no evidence of mutagenic effect induced by 6-
methylhepta-3,5-dien-2-one in any of the strains, either in the absence or presence of S9. No 
precipitation was observed at any tested concentrations (Williams, 2009). It is concluded that under 
the test conditions applied, 6-methylhepta-3,5-dien-2-one is not mutagenic in bacteria. 
Pseudo-ionone was tested in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and 
TA102 in the presence or absence of S9. Evidence of toxicity was seen at concentrations of 200 
μg/plate and above in the range finding study. The concentrations tested in the first experiment were 
0.13, 0.64, 3.2, 16, 80, 400 and 2000 μg/plate, and plate incorporation methodology was used. 
Toxicity as evidenced by thinning of the bacterial lawn and/or reduction in revertant counts was 
observed in all strains at 400 μg/plate and above. Severe toxicity was observed at 2000 μg/plate in all 
strains (complete killing of bacteria). In the second experiment the concentration range was therefore 
modified to 12.5, 25, 50, 100, 200 or 400 μg pseudo-ionone/plate, and treatments in the presence of S9 
were carried out according to the pre-incubation method. In the absence of S9 the standard plate 
incorporation method was performed. Evidence of toxicity was observed in all strains at 100 μg 
pseudo-ionone/plate through thinning of bacterial lawn, reduced revertant counts and killing of test 
bacteria, but sufficient data were obtained for a valid assay. Precipitation was observed in the 400 
μg/plate concentration in the presence and absence of S9 in this experiment. The study design 
complies with current recommendations (OECD 471, GLP), and acceptable top concentrations were 
achieved. There was no evidence of any mutagenic effect induced by pseudo-ionone when tested up to 
precipitating concentrations that were clearly bactericidal (Beevers, 2009a). It is concluded that under 
the test conditions applied, pseudo-ionone is not mutagenic in bacteria. 
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2.1.2. In vitro Micronucleus Assays 
6-Methylhepta-3,5-dien-2-one was evaluated in an in vitro micronucleus assay in human peripheral 
blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in the presence and 
absence of rat S9 fraction as an in vitro metabolising system. The assay was performed in accordance 
with OECD 487 and in compliance with GLP. In a preliminary toxicity study a wide range of 
concentrations up to 2000 μg/ml of 6-methylhepta-3,5-dien-2-one was tested. The highest 
concentration used in the main  test (450 μg/ml) was limited by toxicity observed in the preliminary 
study. Cells were stimulated for 48 hours with phytohaemaglutinin to produce exponentially growing 
cells, and then treated for 3 hours (followed by 21 hours recovery) with 0, 225, 325 or 450 μg/ml of 6-
methylhepta-3,5-dien-2-one in the absence of S9 and 0, 225, 300 and 350 μg/ml in the presence of S9 
respectively. The levels of toxicity (reduction in replication index) at the top concentrations were 60 % 
and 51 % without and with S9, respectively. In a parallel assay, cells were treated for 24 hours with 0, 
100, 120 or 150 μg/ml of 6-methylhepta-3,5-dien-2-one in the absence of S9 with no recovery period. 
The top concentration induced 56 % toxicity. There were 2 replicate cultures per treatment, and 1000 
binucleate cells per replicate (i.e. 2000 cells per dose) were scored for micronuclei. No evidence of 
chromosomal damage or aneuploidy was observed by increased levels of micronucleated binucleate 
cells (MNBN) in the presence or absence of S9 metabolic activation (Whitwell, 2010a). Under the 
conditions of this study, 6-methylhepta-3,5-dien-2-one was not clastogenic and/aneugenic in cultured 
human lymphocytes. 
Similarly, pseudo-ionone was evaluated in an in vitro micronucleus assay in human peripheral blood 
lymphocytes for its ability to induce chromosomal damage or aneuploidy in the presence and absence 
of rat S9 fraction as an in vitro metabolising system. The assay was performed in accordance with 
OECD 487 and in compliance with GLP. The concentrations tested in the main test was based on 
toxicity in a preliminary toxicity study. In the main test the following concentrations were analysed: 
1. 3 + 21 hour without S9: 30, 50 and 60 µg/ml  
2. 3 + 21 hour with S9: 100, 110 and 120 µg/ml 
3. 24 hour without S9: 10, 15 and 20 µg/ml. 
Cells were stimulated for 48 hours with phytohaemaglutinin to produce exponentially growing cells, 
and then treated for 3 hours (followed by 21 hours recovery) with 0, 30, 50 or 60 μg/ml of pseudo-
ionone in the absence of S9 and 0, 100, 110 and 120 μg/ml in the presence of S9 respectively. The 
levels of toxicity (reduction in replication index) at the top concentrations were 54 % and 48 % after 3 
hour treatment without and with S9 respectively and 60 % after 24 hour treatment without S9. 
Although the target range of 50-60 % toxicity was not achieved in the presence of S9, the next highest 
concentration (110 μg/ml) produced 81 % toxicity, which was too high. Given the steepness of the 
toxicity curve, it is considered that 48 % toxicity is sufficiently close to the target range as to be 
acceptable. In a parallel assay, cells were treated for 24 hours with 0, 10, 15 or 20 μg/ml of pseudo-
ionone in the absence of S9 with no recovery period. The top concentration induced 56 % toxicity. 
There were 2 replicate cultures per treatment, and 1000 binucleate cells per replicate (i.e. 2000 cells 
per dose) were scored for micronuclei. Treatment with pseudo-ionone under all described conditions 
resulted in MNBN frequencies that were comparable to and not significantly different from control 
groups (Lloyd, 2010). 
It was noted that after 24 hours exposure in the absence of S9-mix there was a dose related increase in 
micronucleated cells, which was statistically significant at the highest concentration tested (20 μg/ml). 
The mutation frequency was 1.2 % MNBN in both cultures compared to 0.5 in the control. However 
this increase was within the negative control range (0.1 – 1.2) and therefore not considered as 
biological relevant.  
Under the conditions of this study, pseudo-ionone was not clastogenic and/aneugenic in cultured 
human lymphocytes. 
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2.2. In vivo Data 
Based on the in vitro data available no in vivo data are needed.  
2.3. Discussion of Mutagenicity/Genotoxicity Data 
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] and pseudo-ionone [FL-no: 07.198] were tested for all 
three genetic endpoints, gene mutations, structural and numerical chromosomal aberrations. The test 
compounds did not induce gene mutations in bacteria and were not clastogenic and/or aneugenic in 
mammalian cells in vitro.  
Although both flavouring substances showed evidence of cytotoxicity at high concentrations, they did 
not induce biologically significant genotoxic responses. 
3. Conclusion 
The Panel concluded that the in vitro genotoxicity data on these two representative substances do not 
indicate genotoxic potential. Accordingly, all 12 substances in FGE.19 subgroup 1.2.3 are not 
considered to be of concern with respect to genotoxicity and will then be evaluated through the 
Procedure. 
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 206 (JECFA, 2009B; JECFA, 2002D)  
Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in 
ethanol 2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
02.145 
 
2,6-Dimethylocta-1,5,7-trien-3-ol    
OH
- 
- 
29414-56-0 
Liquid 
C10H16O 
152.24 
Slightly soluble 
Freely soluble 
240 
n.a. 
MS 
95 % 
1.484-1.490 
0.895-0.901 
02.194 
 
Octa-1,5-dien-3-ol    OH
 
- 
- 
83861-74-9 
Liquid 
C8H14O 
126.20 
Practically 
insoluble or 
insoluble 
Freely soluble 
187 
n.a. 
MS 
95 % 
1.441-1.447 
0.832-0.838 
02.211 
 
Undeca-1,5-dien-3-ol    OH
 
- 
- 
56722-23-7 
Liquid 
C11H20O 
168.28 
Practically 
insoluble or 
insoluble 
Freely soluble 
244 
n.a. 
NMR 
95 % 
1.456-1.462 
0.872-0.878 
02.252 
1841 
4,8-Dimethyl-3,7-nonadien-2-ol OH
 
4102 
- 
67845-50-5 
Liquid 
C11H20O 
168 
Insoluble 
Soluble 
70 (2.6 hPa) 
n.a. 
- 
95 % 
1.465-1.473 
0.860-0.870 
07.099 
1134 
6-Methylhepta-3,5-dien-2-one O
 
3363 
11143 
1604-28-0 
Liquid 
C8H12O 
124.18 
Almost insoluble 
Miscible 
190 
n.a. 
NMR 
96 % 
1.528-1.537 
0.895-0.899 
07.190 
1848 
Octa-1,5-dien-3-one    
 
O
 
4405 
- 
65213-86-7 
Liquid 
C8H12O 
124.18 
Practically 
insoluble or 
insoluble 
Freely soluble 
169 
n.a. 
MS 
95 % 
1.438-1.444 
0.823-0.829 
07.198 
 
Pseudo-ionone    O
 
4299 
11191 
141-10-6 
Liquid 
C13H20O 
192.30 
Insoluble 
Freely soluble 
144 (16 hPa) 
n.a. 
MS 
95 % 
1.529-1.535 
0.894-0.903 
07.204 
 
3,3,6-Trimethylhepta-1,5-dien-4-one O - 
- 
546-49-6 
Liquid 
C10H16O 
152.24 
Practically 
insoluble or 
insoluble 
Freely soluble 
181 
n.a. 
MS 
95 % 
1.462-1.468 
0.867-0.873 
07.247 
1139 
(E,E)-3,5-Octadien-2-one O
 
4008 
- 
30086-02-3 
Liquid 
C8H12O 
124.2 
Insoluble 
Miscible 
220 
n.a. 
NMR 
95 % 
1.508-1.516 
0.880-0.890 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in 
ethanol 2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
07.253 
1139 
3,5-Octadiene-2-one O
 
- 
- 
30086-02-3 
Liquid 
C8H12O 
124.18 
 
Freely soluble 
84 (13 hPa) 
n.a. 
MS 
95 % 
1.509-1.515 
0.867-0.873 
07.256 
1137 
(3Z)-4,8-Dimethyl-3,7-nonadiene-2-one 
O
3969 
- 
817-88-9 
Liquid 
C11H18O 
166.26 
Insoluble 
Freely soluble 
200-201 
n.a. 
IR NMR 
94 
1.473-1.477 
0.869-0.875 
09.936 
1847 
4,8-Dimethyl-3,7-nonadien-2-yl acetate 
O
O
4103 
- 
91418-25-6 
Liquid 
C13H22O2 
210 
Insoluble 
Soluble 
75-83 (3 hPa) 
n.a. 
- 
95 % 
1.451-1.459 
0.890-0.900 
1) Solubility in water, if not otherwise stated.  
2) Solubility in 95 %  ethanol, if not otherwise stated.  
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated  
5) At 25°C, if not otherwise stated.  
n.a. not applicable.   
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TABLE 2: CURRENT SAFETY EVALUATION STATUS APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
(JECFA, 2009C; JECFA, 2002C) 
Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure path 3) 
JECFA Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the named 
compound 
(genotoxicity) 
 
02.252 
1841 
4,8-Dimethyl-3,7-nonadien-2-ol OH 3.0 
- 
Class I 
A3: Intake below threshold 
4) Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
07.099 
1134 
6-Methylhepta-3,5-dien-2-one O 13 
5 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
07.190 
1848 
Octa-1,5-dien-3-one O 0.061 
- 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
07.247 
1139 
(E,E)-3,5-Octadien-2-one O 3.4 
4 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
07.253 
1139 
3,5-Octadiene-2-one O 0.011 
3 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
07.256 
1137 
(3Z)-4,8-Dimethyl-3,7-nonadiene-2-
one 
O
6.1 
6.6 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
09.936 
1847 
4,8-Dimethyl-3,7-nonadien-2-yl 
acetate 
O
O
3.0 
- 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
02.145 
 
2,6-Dimethylocta-1,5,7-trien-3-ol 
OH
0.0085 
- 
Class II 
No evaluation 
Not evaluated by JECFA Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
02.194 
 
Octa-1,5-dien-3-ol OH 0.061 
- 
Class II 
No evaluation 
Not evaluated by JECFA Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
02.211 
 
Undeca-1,5-dien-3-ol OH 0.061 
- 
Class II 
No evaluation 
Not evaluated by JECFA Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
Flavouring Group Evaluation 206
 
 
12 
 
EFSA Journal 2011; 9(3):1922 
Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure path 3) 
JECFA Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the named 
compound 
(genotoxicity) 
 
07.198 
 
Pseudo-ionone O 0.12 
- 
Class II 
No evaluation 
Not evaluated by JECFA Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
07.204 
 
3,3,6-Trimethylhepta-1,5-dien-4-one O 0.012 
- 
Class II 
No evaluation 
Not evaluated by JECFA Evaluated in FGE.206, genotoxicity 
concern could be ruled out. 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
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TABLE 3: GENOTOXICITY (IN VITRO)  
Table 3: Summary of Additionally submitted genotoxicity data on the representative substance of subgroup 1.2.3 
FL-no Chemical Name Test System in vitro  Test Object  Concentrations of Substance and 
Test Conditions  
Result  Reference  Comments  
[07.099] 6-Methylhepta-3,5-dien-2-one  Reverse Mutation S. typhimurium TA98, 
TA100, TA1535, TA1537 
and TA102 
1.6, 8, 40, 200, 1000 and 5000 
μg/plate [1]  
Negative (Williams, 2009) Toxicity observed in all strains at 2000 μg/plate or 
greater in the absence of S9 and at 800 μg/plate in the 
presence of S9. Study design complied with current 
recommendations. Acceptable top concentration was 
achieved. 20.48, 51.2, 128, 320, 800, 2000 and 5000 μg/plate [1,2] 
Negative 
Micronucleus induction Human peripheral blood 
lymphocytes 
225, 325 and 450 μg/ml [3] 225, 
300 and 350 μg/ml [4] 
Negative (Whitwell, 2010a) Complies with draft OECD guideline 487. 
Acceptable levels of cytotoxicity achieved at the top 
concentrations used in all parts of the study. 
100, 120 or 150 μg/ml [5] Negative 
[07.198] Pseudo-ionone  Reverse Mutation S. typhimurium TA98, 
TA100, TA1535, TA1537 
and TA102 
0.128, 0.64, 3.2, 16, 80, 400 and 
2000 μg/plate [1] 
Negative (Beevers, 2009a) Toxicity was observed in all strains at 400 μg/plate 
and greater in the presence and absence of S9 in this 
experiment. 
0.12.5, 25, 50, 100, 200 and 400 
μg/plate [1,2] 
Negative Precipitation was observed in the 400 μg/plate 
concentration in the presence and absence of S9 in 
this experiment. Study design complies with current 
recommendations. Acceptable top concentrations 
were achieved. 
Micronucleus induction Human peripheral blood 
lymphocytes 
30, 50 and 60 μg/ml [3] 100, 110 
and 120 μg/ml [4] 
Negative (Lloyd, 2010) Complies with draft OECD guideline 487. 
Acceptable levels of cytotoxicity achieved at the top 
concentrations used in all parts of the study. 10, 15 and 20 μg/ml [5] Negative 
[1] With and without metabolic activation. 
[2] Assay modified with pre-incubation in the presence of S9. 
[3] Without metabolic activation, 3 hours treatment + 21 hours recovery. 
[4] With metabolic activation, 3 hours treatment + 21 hours recovery. 
[5] Without metabolic activation, 24 hours + 0 hours recovery. 
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ABBREVIATIONS 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CoE  Council of Europe 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good Laboratory Practice 
ID  Identity 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MNBN  MicroNucleated BiNucleate cells 
MS  Masse spectra 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NMR  Nuclear Magnetic Resonance 
No  Number 
NOAEL No observed adverse effect level 
NTP  National Toxicology Program 
OECD  Organisation for Economic Co-operation and Development 
(Q)SAR (Quantitative ) Structure Activity Relationship 
SCF  Scientific Committee on Food 
WHO  World Health Organisation 
 
 
